886 related articles for article (PubMed ID: 31062833)
1. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
[TBL] [Abstract][Full Text] [Related]
2. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
[TBL] [Abstract][Full Text] [Related]
3. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
[TBL] [Abstract][Full Text] [Related]
4. A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
Grassi M; Perna G; Caldirola D; Schruers K; Duara R; Loewenstein DA
J Alzheimers Dis; 2018; 61(4):1555-1573. PubMed ID: 29355115
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease.
Ezzati A; Lipton RB;
J Alzheimers Dis; 2020; 74(1):55-63. PubMed ID: 31985462
[TBL] [Abstract][Full Text] [Related]
6. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
7. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
Xu L; Wu X; Chen K; Yao L
Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
[TBL] [Abstract][Full Text] [Related]
8. Influence of medical domain knowledge on deep learning for Alzheimer's disease prediction.
Ljubic B; Roychoudhury S; Cao XH; Pavlovski M; Obradovic S; Nair R; Glass L; Obradovic Z
Comput Methods Programs Biomed; 2020 Dec; 197():105765. PubMed ID: 33011665
[TBL] [Abstract][Full Text] [Related]
9. Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials.
Langford O; Raman R; Sperling RA; Cummings J; Sun CK; Jimenez-Maggiora G; Aisen PS; Donohue MC
J Prev Alzheimers Dis; 2020; 7(4):213-218. PubMed ID: 32920622
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tau accumulation in prodromal Alzheimer's disease using an ensemble machine learning approach.
Kim J; Park Y; Park S; Jang H; Kim HJ; Na DL; Lee H; Seo SW
Sci Rep; 2021 Mar; 11(1):5706. PubMed ID: 33707488
[TBL] [Abstract][Full Text] [Related]
11. Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer's Disease: Retrospective Medical Record Review Study and a Nested Case-control Design.
Bature F; Pang D; Robinson A; Polson N; Pappas Y; Guinn B
Curr Alzheimer Res; 2018; 15(8):723-730. PubMed ID: 29623839
[TBL] [Abstract][Full Text] [Related]
12. How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
Epelbaum S; Paquet C; Hugon J; Dumurgier J; Wallon D; Hannequin D; Jonveaux T; Besozzi A; Pouponneau S; Hommet C; Blanc F; Berly L; Julian A; Paccalin M; Pasquier F; Bellet J; Boutoleau-Bretonniere C; Charriau T; Rouaud O; Madec O; Mouton A; David R; Bekadar S; Fabre R; Liegey E; Deberdt W; Robert P; Dubois B
BMJ Open; 2019 Jun; 9(6):e029663. PubMed ID: 31239309
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
[TBL] [Abstract][Full Text] [Related]
14. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
Beheshti I; Demirel H; Matsuda H;
Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
[TBL] [Abstract][Full Text] [Related]
15. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Chang CH; Lin CH; Lane HY
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803217
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease Diagnosis Based on Cortical and Subcortical Features.
Gupta Y; Lee KH; Choi KY; Lee JJ; Kim BC; Kwon GR
J Healthc Eng; 2019; 2019():2492719. PubMed ID: 30944718
[TBL] [Abstract][Full Text] [Related]
19. A novel method for early diagnosis of Alzheimer's disease based on pseudo Zernike moment from structural MRI.
Gorji HT; Haddadnia J
Neuroscience; 2015 Oct; 305():361-71. PubMed ID: 26265552
[TBL] [Abstract][Full Text] [Related]
20. TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.
Jimenez-Maggiora GA; Bruschi S; Raman R; Langford O; Donohue M; Rafii MS; Sperling RA; Cummings JL; Aisen PS
J Prev Alzheimers Dis; 2020; 7(4):226-233. PubMed ID: 32920624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
